Professor Elio Riboli is Director of the School of Public Health at Imperial College London, rated one of the top two epidemiology and public health submissions to the UK’s Research Assessment Exercise (RAE) in 2009. He holds an M.D. degree (1977, State University of Milan), a Master of Public Health (1980, Milan) and a Master of Science in Epidemiology (1982, Harvard University). Professor Riboli is a Registered Physician (General Medical Council, UK, 2005) and an Honorary Fellow of the Royal College of Physicians (2008).
From 1983 to 2005 Professor Riboli was based at Lyon’s the International Agency for Research on Cancer (IARC), where he developed new research projects in the areas of nutrition, nutritional status and cancer. In 1989 he initiated the European Prospective Investigation into Cancer and Nutrition (EPIC), which sampled data from 500,000 subjects across 26 centres in ten countries. He was Head of the Nutrition and Hormones Group of IARC from 2004 to 2005.
Professor Riboli has co-authored over 310 peer-reviewed publications and over 100 book chapters and books and serves on editorial boards of major journals on nutrition, cancer and epidemiology.
In 2005 he joined Imperial College London as Professor of Cancer Epidemiology; in 2006 he was appointed Divisional Head of Epidemiology, Public Health and Primary Care, and became Director when the School of Public Health was established in January 2010.
et al., 2016, A treelet transform analysis to relate nutrient patterns to the risk of hormonal receptor-defined breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC), Public Health Nutrition, Vol:19, ISSN:1368-9800, Pages:242-254
et al., 2016, Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study, European Journal of Nutrition, Vol:55, ISSN:1436-6207, Pages:1359-1375
et al., 2016, Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study (vol 16, pg 331, 2015), Bmc Musculoskeletal Disorders, Vol:17, ISSN:1471-2474
et al., 2016, Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study, Inflammatory Bowel Diseases, Vol:22, ISSN:1078-0998, Pages:345-354
et al., 2016, Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohort, International Journal of Cancer, Vol:138, ISSN:0020-7136, Pages:1129-1138